Universitätsklinikum Hamburg-Eppendorf
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1989-05-19
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.uke.de
Effect of EEG-guided General Anesthesia on Cumulative Dose of Norepinephrine
Not Applicable
Completed
- Conditions
- Hypotension
- Interventions
- Device: EEG-guided general anesthesia
- First Posted Date
- 2022-03-24
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 110
- Registration Number
- NCT05293288
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Pharmacokinetic of Posaconazole in Critically Ill Patients
Completed
- Conditions
- Critical IllnessTherapeutic Drug Monitoring
- Interventions
- Other: Posaconazole Therapeutic Drug Monitoring
- First Posted Date
- 2022-03-11
- Last Posted Date
- 2022-11-08
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 10
- Registration Number
- NCT05275179
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Crossmodal Learning in Therapeutic Processes (Task 2-2)
Not Applicable
Terminated
- Conditions
- Sensory Ataxia
- Interventions
- Other: Placebo ControlDevice: Vibro-tactile stimulation
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 23
- Registration Number
- NCT05262712
- Locations
- 🇩🇪
Universitätsklinikum Hamburg-Eppendorf, Neurologie, Hamburg, Germany
Crossmodal Learning in Therapeutic Processes (Task 2-1)
Not Applicable
Suspended
- Conditions
- Stroke
- Interventions
- Device: Vibro-tactile stimulationOther: Placebo Control
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 44
- Registration Number
- NCT05262699
- Locations
- 🇩🇪
Universitätsklinikum Hamburg-Eppendorf, Neurologie, Hamburg, Germany
Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families
Completed
- Conditions
- HepatoblastomaNephroblastomaNeuroblastoma
- First Posted Date
- 2022-02-17
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 100
- Registration Number
- NCT05245123
- Locations
- 🇩🇪
University Medical Center Mannheim, Mannheim, Baden-Württemberg, Germany
🇩🇪University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Disentangling Pharmacological and Expectation Effects in Antidepressant Discontinuation
Not Applicable
Active, not recruiting
- Conditions
- Depressive SymptomsExpectationsAntidepressants
- Interventions
- Drug: Treatment 'discontinuation of antidepressant medication'Drug: Treatment 'continuation of antidepressant medication'Behavioral: Expectation 'high'Behavioral: Expectation 'moderate'
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 56
- Registration Number
- NCT05191277
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Child and Adolescent Psychiatric Personality Structure
Completed
- Conditions
- Personality DisordersSocial Withdrawal of Childhood or AdolescencePsychosocial Impairment
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 62
- Registration Number
- NCT05162287
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Intubation-induced Decrease in Heart Rate as an Indicator for Intraoperative Bradycardia
Completed
- Conditions
- Airway ManagementHeart RateTracheal Intubation
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 50
- Registration Number
- NCT05160207
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial
Phase 2
Terminated
- Conditions
- COVID-19
- Interventions
- Biological: Adrecizumab (HAM 8101)Drug: Placebo
- First Posted Date
- 2021-12-14
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 16
- Registration Number
- NCT05156671
- Locations
- 🇩🇪
Universitätsklinikum Essen, Essen, Germany
🇩🇪Universitätsklinikum Frankfurt, Frankfurt, Germany
🇩🇪Charité, Berlin, Germany
Clinical Implementation and Evaluation for the Family-oriented Care CHIMPS-NET
Not Applicable
- Conditions
- Mental Health Issue
- Interventions
- Behavioral: Optimal pathways to careOther: TAUBehavioral: Education and training program for the professionalsBehavioral: Systematic screening
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2021-11-04
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 798
- Registration Number
- NCT05106673
- Locations
- 🇩🇪
Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
© Copyright 2025. All Rights Reserved by MedPath